GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […]
European Medicines Agency panel OKs GW Pharma’s cannabis drug is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
source https://hempgenixs.com/2019/07/26/european-medicines-agency-panel-oks-gw-pharmas-cannabis-drug/?utm_source=rss&utm_medium=rss&utm_campaign=european-medicines-agency-panel-oks-gw-pharmas-cannabis-drug
No comments:
Post a Comment